TD Cowen maintained a Buy rating on Boston Scientific on June 25, 2026.
1 report, 1 independent
Updated Jun 25
AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.
What happened
TD Cowen maintained a Buy rating on Boston Scientific on June 25, 2026.
Who's involved
What this event is mainly aboutKeep exploring
The entities involved
-
TD Cowen
American investment bank
-
Boston Scientific
worldwide developer, manufacturer and marketer of medical devices
Related events
- TD Cowen raised its price target and issued a buy rating for Globe Life.
- TD Cowen issued a buy rating and price target for Dexcom on October 9, 2026.
- Bio-Techne shares traded on Nasdaq, and TD Cowen reiterated a Buy rating with a $65 price target.
- TD Cowen lifted its price target and gave a buy rating for Hilton Worldwide.
- TD Cowen reaffirmed a buy rating on Alaska Airlines.